| William E Swiler, DO | |
|
90 Hope Dr, Mountain Home A F B, ID 83648-1057 | |
| (208) 828-7401 | |
| Not Available |
| Full Name | William E Swiler |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 90 Hope Dr, Mountain Home A F B, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861488413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 0-319 (Idaho) | Secondary |
| 207P00000X | Emergency Medicine | 7284305-1204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeview Hospital | Bountiful, UT | Hospital |
| St Mark's Hospital | Salt lake city, UT | Hospital |
| Jordan Valley Medical Center | West jordan, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Physicians Integrated Care Llc | 4284548116 | 170 |
News Archive
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.
Acorda Therapeutics, Inc, today announced that data from preclinical studies show that Glial Growth Factor 2 (GGF2) promoted functional recovery following a permanent focal ischemic stroke.
Prestige Brands Holdings, Inc. today announced results for the third fiscal quarter and nine months ending December 31, 2009.
› Verified 4 days ago
| Entity Name | Emergency Physicians Integrated Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598199 PECOS PAC ID: 4284548116 Enrollment ID: O20031115000013 |
News Archive
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.
Acorda Therapeutics, Inc, today announced that data from preclinical studies show that Glial Growth Factor 2 (GGF2) promoted functional recovery following a permanent focal ischemic stroke.
Prestige Brands Holdings, Inc. today announced results for the third fiscal quarter and nine months ending December 31, 2009.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William E Swiler, DO 140 War Eagle Dr, Mountain Home, ID 83647-3784 Ph: (208) 580-2158 | William E Swiler, DO 90 Hope Dr, Mountain Home A F B, ID 83648-1057 Ph: (208) 828-7401 |
News Archive
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
Bloomberg examines Secretary of State Hillary Rodham Clinton's "fervor for making women's advancement a core part of her national-security efforts." According to the news service, Clinton "has been pushing the cause from remote Congolese villages to the United Nations General Assembly.
Acorda Therapeutics, Inc, today announced that data from preclinical studies show that Glial Growth Factor 2 (GGF2) promoted functional recovery following a permanent focal ischemic stroke.
Prestige Brands Holdings, Inc. today announced results for the third fiscal quarter and nine months ending December 31, 2009.
› Verified 4 days ago